NCT01516255
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Fargo, North Dakota, United States
Clinical trial condition
Diabetes
Explore clinical trials studying Diabetes. Study availability and eligibility vary by location and protocol.
2,489 public trials
175 recruiting studies
Diabetes trial results
NCT00154401
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Aalborg, Denmark
- Novo Nordisk Investigational Site Århus C, Denmark
- Novo Nordisk Investigational Site Copenhagen, Denmark
- Novo Nordisk Investigational Site Hellerup, Denmark
NCT00333151
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Goodyear, Arizona, United States
- Novo Nordisk Investigational Site Colton, California, United States
- Novo Nordisk Investigational Site Concord, California, United States
- Novo Nordisk Investigational Site Escondido, California, United States
NCT01515592
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
NCT01511172
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Daw Park, South Australia, Australia
- Novo Nordisk Investigational Site Adelaide, Australia
- Novo Nordisk Investigational Site Ashford, Australia
- Novo Nordisk Investigational Site Garran, Australia
NCT00154414
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
NCT00318422
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Buenos Aires, Argentina
- Novo Nordisk Investigational Site Buenos Aires, Argentina
- Novo Nordisk Investigational Site Buenos Aires, Argentina
- Novo Nordisk Investigational Site Córdoba, Argentina
NCT01620476
- Conditions
- Diabetes, Diabetes Mellitus, Endocrine System Diseases, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tokyo, Japan
Completed
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
NCT01508923
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Århus C, Denmark
Completed
Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With Type 1 Diabetes
NCT00419718
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
- Locations
-
- Novo Nordisk Investigational Site Graz, Austria